Health Sciences Grants

Health Sciences Research Awards and Grants

Title Type $ Amount Activity Investigator Unit Sponsor Date
A Phase 3, Randomized, Open-label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-cell Lymphoma (DLB Contract 1,097,975.93 Clinical Trial Abhijeet Kumar Cancer Center Division AbbVie Incorporated 11/2023
A Phase 4, Global, Prospective, Open label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clin Contract 169,895.50 Clinical Trial Sasha Taleban Medicine Celgene Corporation 11/2023
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec Contract 1,286,672.52 Clinical Trial Christian Bime Medicine Astrazeneca 11/2023
Accelerated Insulin Absorption by Administration Through a Miniature Subcutaneously Implanted Vascularized Chamber Grant 99,360.00 Research Klearchos Papas Surgery Procyon Technologies, LLC 11/2023
Achieving Equity in Farmworker Health Through Community-Led Research Contract 445,438.00 Research Maia Ingram Health Promotion Sciences Campesinos Sin Fronteras 11/2023
An Interventional, Multi-Center Investigation of Single-Level Lumbar Interbody Fusion Stabilized With Pedicle Screws Contract 2,887,900.00 Clinical Trial Richard Chua Neurosurgery 3Spine Management Company, Inc. 11/2023
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis Contract 118,430.00 Clinical Trial Sachin Chaudhary Medicine United Therapeutics Corporation 11/2023
Atricure Testing Contract 34,292.00 Research Steven Goldman Sarver Heart Center AtriCure Inc 11/2023
Building the Next Generation of Academic Physicians (BNGAP): Designing, Implementing, and Evaluating Pre-Faculty Development Teaching and Assessment Materials Grant 22,500.00 Research Guadalupe Martinez COM Phx Internal Medicine Josiah Macy, Jr. Foundation 11/2023
COVID-19 and Influenza Vaccine Update Initiative for Older Adults and People with Disabilities Grant 79,800.00 Other Sponsored Activity Jacy Farkas Family and Community Medicine Association of University Centers on Disability 11/2023
cps1 vaccine to prevent blastomycosis in mouse models of disease Contract 164,702.00 Research Lisa Shubitz Valley Fever Ctr for Excellnc Anivive Lifesciences, Inc 11/2023
DNA Repair Germline Mutation as a Predictor of Gastric Adenoma Development and Treatment in H. pylori Infection Fellowship 48,500.00 Research Training Isabel Alvarado Cancer Center Division University of Arizona Foundation 11/2023
IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 Contract 436,656.48 Clinical Trial Franz Rischard Medicine Aerovate Therapeutics 11/2023
Improving Spinal Growth Modulation Using a Novel Kyphotic Porcine Model Grant 179,899.00 Research Matthew Halanski COM Phx Child Health National Institute of Arthritis and Musculoskeletal and Skin Diseases 11/2023
Integrated Islet Distribution Program (U24) - 2021 Cooperative Agreement 300,000.00 Research Klearchos Papas Surgery City of Hope 11/2023
Managing Symptoms and Psychological Distress During Oral Anti-cancer Treatment Grant 703,797.00 Research Terry Badger College of Nursing Michigan State University 11/2023
Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health Grant 306,971.00 Research Hee-Dae Kim COM Phx Basic Medical Sci United States Army Medical Research Acquisition Activity 11/2023
Oral Health in Medicine Initiative (OHMI) Contract 850,000.00 Instruction Irene Alexandraki COM Phoenix Academic Affairs Delta Dental of Arizona Foundation 11/2023
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors Contract 352,386.00 Clinical Trial Jennifer Segar Cancer Center Division Vaxiion Therapeutics 11/2023
Phase 2, Proof-of-Concept, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as Add-on Therapy to Standard of Care in Adult Patients With Acu Contract 193,762.24 Clinical Trial Esa Rayyan COM Phx Internal Medicine IQVIA RDS Inc. 11/2023